Market Overview

Ascites| A Drug Pipeline Analysis Report 2018| Technavio


Technavio has announced their latest drug pipeline analysis report on ascites.
The report includes a detailed analysis of the pipeline molecules under
investigation within the defined data collection period to treat ascites.

This press release features multimedia. View the full release here:

Technavio has published a new report on the drug development pipeline for ascites, including a detai ...

Technavio has published a new report on the drug development pipeline for ascites, including a detailed study of the pipeline molecules (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

Ascites: Market overview

Ascites refers to the accumulation of fluid in the peritoneal cavity.
The organs of the abdomen are situated in a sac-like structure called
the peritoneum. Generally, the amount of fluid in the peritoneal
activity is very less. This can vary by 20 ml or less than an ounce in
woman depending on the menstrual cycle. A variety of diseases can cause
fluid accumulation. The direct leakage of fluid is an after-effect of
cancer that spreads to the peritoneum. In addition, there are other
illnesses that cause excess accumulation of water and sodium in the
body, which eventually leads to leakage of fluid into the peritoneal

According to a senior market research analyst at Technavio, "The
other causes of ascites include liver disease, the inability of organs
to produce enough protein to retain fluid in the bloodstream and the
obstruction of flow through the scarred cirrhotic liver. The proteins
prevent the leakage of water molecules from capillary blood vessels into
surrounding tissues. The liver's ability to produce proteins is
decreased by the progression of liver disease. This results in a lack of
protein in the body. Water leaks into the surrounding tissues, thus
decreasing oncotic pressure."

Ascites: Segmentation analysis

This pipeline analysis report segments the ascites market based on
therapies employed (monotherapy), RoA (intravenous and intraperitoneal),
therapeutic modality (peptide, monoclonal antibody, fusion protein,
recombinant protein, and bispecific antibody), targets (CLEC10A
receptor, TRAIL receptor, tubulin, AVPR1 and AVPR2, vasopressin type 2
receptor, B7-H3 (CD276), and EpCAM and CD3 ), MoA (CLEC10A receptor
agonist, TRAIL receptor agonist, tubulin inhibitor, AVPR1 and AVPR2
agonist, immunostimulator, vasopressin type 2 receptor antagonist, B7-H3
(CD276) inhibitor, and EpCAM and CD3 inhibitor), geographical
segmentation (US and Australia) and recruitment status (recruiting). It
provides an in-depth analysis of the prominent factors influencing the
market, including drivers, opportunities, trends, and industry-specific

Based on therapeutic modality, more than 36% of the molecules that are
being investigated for the treatment of ascites are peptide, which is a
short chain of amino acids

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team

View Comments and Join the Discussion!